News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,684 Results
Type
Article (41059)
Company Profile (225)
Press Release (643398)
Multimedia
Podcasts (120)
Webinars (15)
Section
Business (217478)
Career Advice (917)
Deals (33205)
Drug Delivery (142)
Drug Development (79883)
Employer Resources (73)
FDA (14916)
Job Trends (12852)
News (324558)
Policy (29935)
Tag
2025 Best Places to Work (1)
2026 Best Places to Work (1)
2027 BioCapital Standard (2)
2027 BioMidwest Digital (1)
2027 BioMidwest Standard (3)
2027 Bio NC Standard (3)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (4)
2027 Genetown Elite (2)
2027 Genetown Premier (1)
2027 Genetown Standard (6)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (9)
40 Under 40 (2)
Academia (2054)
Academic (1)
Accelerated approval (66)
ADA (36)
Adcomms (29)
Allergies (175)
Alliances (47374)
ALS (190)
Alzheimer's disease (1656)
Antibody-drug conjugate (ADC) (721)
Approvals (15668)
Artificial intelligence (767)
ASCO (344)
Autoimmune disease (389)
Automation (55)
Bankruptcy (341)
Belgium (22)
Best Places to Work (9861)
BIO (59)
Biologics (68)
BIOSECURE Act (14)
Biosimilars (245)
BioSpace Insights (107)
Biotechnology (143)
Bispecific (43)
Bladder cancer (242)
Brain cancer (98)
Breast cancer (961)
Cancer (7767)
Cardiovascular disease (480)
Career advice (808)
Career pathing (22)
CAR-T (398)
CDC (46)
CDMO (150)
Celiac Disease (6)
Cell therapy (976)
Cervical cancer (66)
Clinical research (71205)
Collaboration (2338)
Commercialization (45)
Company closure (8)
Compensation (1702)
Complete response letters (95)
COVID-19 (2298)
CRISPR (115)
CRO (2)
C-suite (1369)
Cystic fibrosis (143)
Data (9373)
Decentralized trials (3)
Denatured (32)
Depression (142)
Dermatology (139)
Diabetes (631)
Diagnostics (6488)
Digital health (60)
Diversity (9)
Diversity, equity & inclusion (22)
Drug discovery (364)
Drug pricing (153)
Drug shortages (19)
Duchenne muscular dystrophy (265)
Earnings (86540)
Editorial (42)
Employer branding (6)
Employer resources (67)
ESMO (431)
Events (114674)
Executive appointments (1143)
Eye disease (10)
FDA (19115)
Fibrodysplasia Ossificans Progressiva (14)
Fragile X (4)
Friedreich's ataxia (24)
Frontotemporal dementia (33)
Funding (1815)
Gene editing (217)
Generative AI (57)
Gene therapy (637)
GLP-1 (873)
Government (3827)
Grass and pollen (5)
Guidances (378)
Healthcare (15730)
Hematology (195)
HIV (107)
Huntington's disease (43)
Idiopathic pulmonary fibrosis (9)
IgA nephropathy (136)
Immunology and inflammation (272)
Immuno-oncology (149)
Indications (256)
Infectious disease (2685)
Inflammatory bowel disease (227)
Inflation Reduction Act (13)
Influenza (146)
Intellectual property (344)
Interviews (128)
IPO (15290)
IRA (41)
Job creations (3386)
Job search strategy (706)
JPM (45)
Kidney cancer (30)
Kidney disease (135)
Labor market (50)
Layoffs (415)
Leadership (25)
Legal (7501)
Licensing (85)
Liver cancer (119)
Longevity (46)
Lung cancer (1085)
Lung diease (14)
Lymphoma (525)
Machine learning (58)
Management (26)
Manufacturing (1231)
Marketing (32)
MASH (211)
Medical affairs (4)
Medical device (10653)
Medtech (10876)
Mergers & acquisitions (19235)
Metabolic disorders (1467)
mRNA (251)
Multiple sclerosis (192)
Multispecific (5)
NASH (16)
Netherlands (10)
Neurodegenerative disease (401)
Neuropsychiatric disorders (88)
Neuroscience (3136)
Neurotech (3)
NextGen: Class of 2026 (5144)
Non-profit (3462)
Now hiring (40)
Obesity (592)
Opinion (242)
Ovarian cancer (295)
Pain (297)
Pancreatic cancer (449)
Parkinson's disease (334)
Partnered (32)
Patents (721)
Patient advocacy (5)
Patient recruitment (836)
Patient selection (85)
Peanut (48)
People (56470)
Peptides (26)
Pharmaceutical (52)
Pharmacy benefit managers (28)
Phase 1 (22326)
Phase 2 (31067)
Phase 3 (23343)
Pipeline (11983)
Policy (248)
Postmarket research (2710)
Preclinical (9588)
Press Release (52)
Prostate cancer (407)
Psychedelics (47)
Radioligand (3)
Radiopharmaceuticals (412)
Rare diseases (1143)
Real estate (5059)
Recruiting (25)
Regenerative medicine (18)
Regulatory (24589)
Reports (34)
Research institute (2200)
Resumes & cover letters (127)
Rett syndrome (52)
RNA editing (26)
RSV (89)
Schizophrenia (182)
Series A (319)
Series B (217)
Service/supplier (5)
Sickle cell disease (130)
Special edition (18)
Spinal muscular atrophy (131)
Sponsored (34)
Startups (3313)
State (2)
Stem cells (3)
Stomach cancer (24)
Substance use disorders (18)
Supply chain (124)
Switzerland (6)
Tariffs (80)
The Weekly (86)
Vaccines (1114)
Venture capital (94)
Weight loss (336)
Wet AMD (4)
Women's health (146)
Women in leadership (1)
Worklife (9)
Date
Today (89)
Last 7 days (725)
Last 30 days (2622)
Last 365 days (27738)
2026 (23106)
2025 (27468)
2024 (31904)
2023 (36494)
2022 (47047)
2021 (50633)
2020 (47648)
2019 (37909)
2018 (28714)
2017 (29198)
2016 (28477)
2015 (34173)
2014 (29416)
2013 (25327)
2012 (27322)
2011 (27719)
2010 (26743)
Location
Africa (653)
Alabama (95)
Alaska (3)
Arizona (390)
Arkansas (15)
Asia (38420)
Australia (6136)
California (15131)
Canada (4199)
China (1655)
Colorado (624)
Connecticut (574)
Delaware (415)
Europe (77900)
Florida (2304)
Georgia (474)
Hawaii (3)
Idaho (50)
Illinois (1131)
India (128)
Indiana (683)
Iowa (25)
Japan (686)
Kansas (138)
Kentucky (52)
Louisiana (54)
Maine (33)
Maryland (1715)
Massachusetts (10445)
Michigan (358)
Minnesota (724)
Mississippi (6)
Missouri (132)
Montana (35)
Nebraska (19)
Nevada (147)
New Hampshire (76)
New Jersey (3976)
New Mexico (27)
New York (3907)
North Carolina (1802)
North Dakota (5)
Northern California (7750)
Ohio (392)
Oklahoma (21)
Oregon (39)
Pennsylvania (2954)
Puerto Rico (34)
Rhode Island (46)
South America (917)
South Carolina (92)
South Dakota (1)
Southern California (6148)
Tennessee (199)
Texas (2514)
United States (52140)
Utah (447)
Vermont (1)
Virginia (369)
Washington D.C. (63)
Washington State (1217)
West Virginia (2)
Wisconsin (176)
Wyoming (4)
684,684 Results for "cancer prevention pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Human Longevity Expands Its $1 Million Cancer Prevention Pledge to Breast Cancer
October 18, 2026
·
2 min read
Press Releases
Next-Gen Drug Significantly Prevents Return of and Death From Endometrial Cancer
October 26, 2026
·
6 min read
Press Releases
Vanda Pharmaceuticals Announces Positive Results from Study 3601 of NEREUS™ (tradipitant) for Prevention of GLP-1-Induced Vomiting
October 27, 2026
·
9 min read
Press Releases
Devonian Health Group Receives Health Canada Authorization to Evaluate Novel Thykamine™ Formulation for Prevention of Radiation-Induced Skin Injury in Breast Cancer Patients
October 20, 2026
·
14 min read
Press Releases
Acta Pharmaceuticals Closes $24 Million in Seed Financing for Alzheimer’s Disease Pipeline Targeting Early Intervention and Prevention
October 15, 2026
·
8 min read
Press Releases
SignaBlok to Present Novel Approach to Preventing Cancer Recurrence at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Ligand-independent mechanism of action of SignaBlok’s first-in-class TREM-1 inhibitors enables development of cell-unspecific and macrophage-targeted TREM-1 inhibitors · In experimental pancreatic cancer, macrophage-targeted but not cell-unspecific TREM-1 inhibitor: − prevents cancer recurrence, improves complete response rate and survival, when administered in a time window of 7 days after standard-of-care (SOC) chemotherapy − reverses immunosuppression and overcomes cancer resistance to anti-PD-L1 immunotherapy · Timely resolution of acute inflammation induced by SOC cancer treatments (chemotherapy, surgery, radiation, radiopharmaceuticals, etc.) can be a common approach to prevent cancer recurrence, increase response rate and survival for not only pancreatic cancer but also other hard-to-treat tumors
March 26, 2026
·
1 min read
Press Releases
Nivi, Inc. and MSD Collaborate to Expand HPV Disease Awareness and Cervical Cancer Prevention Through AI-Powered Platform
June 16, 2026
·
4 min read
Press Releases
Cantargia Announces Start of New Investigator-Initiated Lung Cancer Prevention Study
June 10, 2026
·
3 min read
Press Releases
Phio Pharmaceuticals Announces “Innovations in Skin Cancer Treatment and Prevention” in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
Live virtual fireside chat — investors, advisors, and life sciences analysts invited to attend Featuring Dermatologist Mary Spellman, M.D., with Phio CEO Robert Bitterman and Force Family Office CEO Steven Saltzstein
May 12, 2026
·
5 min read
Press Releases
Veloxis Pharmaceuticals Doses First Patient in RENGEVITY-201 Phase 2 Trial of Pegrizeprument for the Prevention of Organ Rejection in Kidney Transplant Recipients
August 31, 2026
·
4 min read
1 of 68,469
Next
